|

Nirogacestat Clinical Trials

5 actively recruiting trials across 3 locations

Also known as: Ogsiveo, PF-03084014

Pipeline

Phase 1: 1Phase 2: 2Phase 4: 1Phase 1/2: 1

Top Sponsors

  • SpringWorks Therapeutics, Inc.1
  • Regeneron Pharmaceuticals1
  • Nam Bui1
  • M.D. Anderson Cancer Center1
  • Hellenic Society of Hematology1

Indications

  • Cancer5
  • Desmoid Tumor2
  • Multiple Myeloma2
  • Corneal Disease1
  • Haematologic Disease1

Other2 trials

A Study to Investigate Safety and Clinical Activity of Belantamab Mafodotin in Combination With Lenalidomide, Dexamethasone and Nirogacestat in Patients With Transplant Ineligible Newly Diagnosed Multiple Myeloma
Phase 1/2
Nirogacestat in Premenopausal Females With Desmoid Tumor/Aggressive Fibromatosis (DT/AF)
Phase 4

La Jolla, California1 trial

A Study to Examine the Effects of Novel Therapy Linvoseltamab in Combination With Other Cancer Treatments for Adult Patients With Multiple Myeloma That is Resistant to Current Standard of Care Treatments

Scripps Clinic Torrey Pines

Phase 1

Palo Alto, California1 trial

Study of Cryoablation and Nirogacestat for Desmoid Tumor

Stanford University

Phase 2

Houston, Texas1 trial

Evaluation of the Response and Non-response of Nirogacestat in Desmoid Tumors- Clinical Study

M D Anderson Cancer Center

Phase 2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.